Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell D Cohen

Showing results (51-60 of 142) with videos related to

Pageof 15
Sort By:
The New England Journal of Medicine|October 4, 2023
Digging into the HistologyRaghavendra Paknikar, Lindsay Alpert, Russell D Cohen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 8, 2023
Risankizumab Effectiveness and Safety in Crohn's Disease: Real-world Data From a Large Tertiary CenterAdar Zinger, David Choi, Natalie Choi, et al.
Gastroenterology|April 14, 2020
AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert CommentaryDavid T Rubin, Joseph D Feuerstein, Andrew Y Wang, et al.
Inflammatory Bowel Diseases|August 30, 2014
Incidence and predictors of clinical response, re-induction dose, and maintenance dose escalation with certolizumab pegol in Crohn's diseaseAdam C Stein, David T Rubin, Stephen B Hanauer, et al.
BMC Gastroenterology|September 26, 2012
Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitisDebanjali Mitra, Paul Hodgkins, Linnette Yen, et al.
Inflammatory Bowel Diseases|February 27, 2016
Age of Diagnosis is Associated with Disease Presentation and Therapeutic Complications in Patients with Crohn's DiseaseAbdo M Saad, Frank Czul, Atsushi Sakuraba, et al.
Inflammatory Bowel Diseases|November 5, 2013
The incidence and predictors of lupus-like reaction in patients with IBD treated with anti-TNF therapiesHenit Yanai, Dmitry Shuster, Emma Calabrese, et al.
Journal of Managed Care Pharmacy : JMCP|December 5, 2012
Medication use patterns and predictors of nonpersistence and nonadherence with oral 5-aminosalicylic acid therapy in patients with ulcerative colitisLinnette Yen, Joanne Wu, Pau L Hodgkins, et al.
Digestive Diseases and Sciences|March 8, 2022
Rare and Well Done: Endoscopic Control of Colonic Hemorrhage in Severe Ulcerative ColitisShintaro Akiyama, Nathaniel A Cohen, Joshua M Steinberg, et al.
Journal for Immunotherapy of Cancer|January 8, 2019
Complete response of metastatic melanoma in a patient with Crohn's disease simultaneously receiving anti-α4β7 and anti-PD1 antibodiesChristopher C Frohne, Ernesto M Llano, Ashley Perkovic, et al.
Pageof 15

Showing results (51-60 of 142) with videos related to

Sort By:
Pageof 15
The New England Journal of Medicine|October 4, 2023
Digging into the HistologyRaghavendra Paknikar, Lindsay Alpert, Russell D Cohen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 8, 2023
Risankizumab Effectiveness and Safety in Crohn's Disease: Real-world Data From a Large Tertiary CenterAdar Zinger, David Choi, Natalie Choi, et al.
Gastroenterology|April 14, 2020
AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert CommentaryDavid T Rubin, Joseph D Feuerstein, Andrew Y Wang, et al.
Inflammatory Bowel Diseases|August 30, 2014
Incidence and predictors of clinical response, re-induction dose, and maintenance dose escalation with certolizumab pegol in Crohn's diseaseAdam C Stein, David T Rubin, Stephen B Hanauer, et al.
BMC Gastroenterology|September 26, 2012
Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitisDebanjali Mitra, Paul Hodgkins, Linnette Yen, et al.
Inflammatory Bowel Diseases|February 27, 2016
Age of Diagnosis is Associated with Disease Presentation and Therapeutic Complications in Patients with Crohn's DiseaseAbdo M Saad, Frank Czul, Atsushi Sakuraba, et al.
Inflammatory Bowel Diseases|November 5, 2013
The incidence and predictors of lupus-like reaction in patients with IBD treated with anti-TNF therapiesHenit Yanai, Dmitry Shuster, Emma Calabrese, et al.
Journal of Managed Care Pharmacy : JMCP|December 5, 2012
Medication use patterns and predictors of nonpersistence and nonadherence with oral 5-aminosalicylic acid therapy in patients with ulcerative colitisLinnette Yen, Joanne Wu, Pau L Hodgkins, et al.
Digestive Diseases and Sciences|March 8, 2022
Rare and Well Done: Endoscopic Control of Colonic Hemorrhage in Severe Ulcerative ColitisShintaro Akiyama, Nathaniel A Cohen, Joshua M Steinberg, et al.
Journal for Immunotherapy of Cancer|January 8, 2019
Complete response of metastatic melanoma in a patient with Crohn's disease simultaneously receiving anti-α4β7 and anti-PD1 antibodiesChristopher C Frohne, Ernesto M Llano, Ashley Perkovic, et al.
Pageof 15